A large number of drugs will be included in the focus of monitoring.

A large number of drugs will be included in the focus of monitoring.
1. Focus on monitoring drugs On June 30, 2020, the First People's Hospital of Neijiang City issued the "Key Monitoring of Rational Drug Use Drugs Catalog (Chemical Drugs and Biological Products)", which is in line with the "Notice on the Issue of the First State Key Monitoring and Rational Drug Products (Chemical Drugs and Biological Products) issued on July 1, 2019.
the notice directory of a total of 20 varieties of neurokines, brain nucleotide, olasitin, sodium phosphocontent, calf serum deprotein, according to the catalog provisions of these varieties of Neijiang City First People's Hospital should be "included in the catalog of all drugs to carry out prescription review and prescription review, strengthen the publication, feedback and utilization of prescription review results."
in accordance with the notification requirements for some pharmaceutical hospitals should "take ranking notification, time-limited rectification, the removal of the agency's drug supply catalogue and other measures to ensure rational drug use."
"In accordance with last year's notice of the National Health and Care Commission's Medical Administration and Hospital Authority, in addition to the state's key monitoring of rational drug use, there are provincial and hospital-level secondary focus on monitoring the catalog of reasonable drugs.
in accordance with the requirements of this two-level key monitoring of reasonable drug catalog needs to be based on the national directory, the formulation of provincial and hospital-level directory, after the formulation should be reported to the National Health and Health Commission and the State Administration of Traditional Chinese Medicine for the record, and must be open to government affairs, open hospital affairs, official website publicity and other forms of public release to the community.
provincial and hospital-level secondary focus monitoring of rational drug catalog of the bottom plate should be a national directory, on the basis of the national directory based on the actual number of varieties, in principle only increase not decrease.
the current state key monitoring of rational drug catalog, has been implemented in various places, clearly made it clear that priority will be the national key monitoring varieties out of the catalog, such as Hubei Province, Zhejiang Province, Jiangsu Province, Fujian Province, Shanghai, Sichuan Province, Shaanxi Province, Gansu Province, Yunnan Province, Chongqing City, Guizhou, Shandong Province, Inner Mongolia, Guangdong Province, Jiangxi and other documents have been published.
2. Which drugs will be included in the key monitoring As stated in the notice, in addition to the national key monitoring of rational drug catalog, provinces and medical institutions can also be issued provincial and the agency focused on monitoring the rational drug catalog, then in this drug three-level monitoring directory of provincial and hospital-level have issued what key monitoring of reasonable drug catalog? First: Provincial Key Monitoring Of Rational Drug Use Drug Catalog October 9, 2019, Zhejiang Provincial Health and Health Commission Office released the "First batch of Zhejiang Province focused on monitoring reasonable drug use catalog, provincial directory a total of 32 varieties, including 20 national-level monitoring drugs, as well as injection thymus new, Kang ai injection, anti-cancer flat injection (intravenous injection), ginseng positive injection, cytophoin sodium, eddy injection injection and other 2 provincial key drug monitoring. In addition to Zhejiang Province,
, Hainan Province, Jiangxi Province, Hubei Province, Guangxi, Shanxi Province, Anhui Province, Ningxia, etc. have published the provincial key monitoring of rational drug use catalog (schedule).
(Note: The author according to the local health and sanitation committee documents statistics) through the above eight provincial key monitoring reasonable drug catalog comparison can be seen, a total of 58 varieties involved in provincial key monitoring varieties, overlapping monitoring varieties lansolafen, radtodazole, danred injection, placenta peptides Injection, dredging injection five varieties, at most only three provinces overlap, due to Gansu Province, Heilongjiang, Jilin Province, Tibet Autonomous Region, Jiangsu Province, Fujian Province, Shanghai, Sichuan Province, Shaanxi Province, Yunnan Province, Chongqing City, Guizhou, Shandong, Inner Mongolia, Guangdong Province are the implementation of the national directory, no new provincial directory.
from 8 provinces alone data, provincial supplementary varieties due to local drug use differences in the habit, in the first batch of key monitoring varieties, the provincial level does not have a unified regularity.
but there is a rule that can be seen that injections account for the majority of the proportion.
second: hospital-level key monitoring of rational drug catalog July 26, 2019, Jiangxi Provincial People's Hospital issued "Jiangxi Provincial People's Hospital key monitoring of rational drug catalog" in addition to the country's 20 varieties, provincial 15 varieties, the hospital also developed a hospital focus on monitoring reasonable drug catalog, a total of Atorvastatin, clopidogrerere, land Zosin, butyl benzene, moxissac, cephalosporine shubatan, iodykessal, takermos, mushroom polysaccharides, ginkgo diazepam glutamine, cephalosporine, merobinan, Conlet, nitrosped, acapone sugar and other 15 hospital-level varieties.
of these 15 hospital-grade varieties, oral drugs accounted for the majority of the proportion, more characteristic is also acapo sugar, atovastatin and other band-purchased varieties.
in addition to Jiangxi Provincial People's Hospital, Jiangxi University of Traditional Chinese Medicine, the second affiliated hospital has added 10 hospital-level varieties, including blood plug-in, magpie equality of large varieties.
hospital-level key monitoring varieties with characteristics are Jinggangshan University Hospital, the new Dizosin injection, injection with thrombosis, mixed sugar electrolyte injection, injection with cephalosporine sodium saubatan sodium, injection with meloppenan, lotus biji injection, ginseng positive injection and other 15 hospital-level varieties are all injections.
in addition to general hospitals, specialized hospitals in the key monitoring varieties also have certain characteristics, such as Nanchang University affiliated oral hospital and Jiangxi Province Cancer Hospital, due to the special nature of the hospital department, the oral hospital only left oxyfluoroxacin, 2 provincial varieties of radora. In addition to national and provincial levels,
Oncology Hospital has added three unique hospital-level varieties of sodium sulphate, Ondansjun, polyethyl glycol recombinant human granulocyte stimulation factors.
through the above-mentioned national, provincial, medical institutions three-level key monitoring of rational drug catalog can be seen, from top to bottom in the variety structure has taken place some changes.
1, from auxiliary drug to targeted drug transfer State-level 20 catalogs of nervous system medication 10, cardiovascular 5, blood and hematopoietic drug 1, immunomodulator 3, bone and muscle medication 1, most of which are auxiliary drugs.
provincial (Jiangxi Province) 15 catalogs of anti-infection 9, blood and hematopoietic drugs 1, anti-tumor 1, cardiovascular 3, digestive system 2.
medical grade catalog further refined to the hospital department habitual drug catalog, with obvious department drug habits, such as Jiangxi Cancer Hospital for chemotherapy leading to vomiting 5-serotonin (5-HT3) receptor antagonist OndanSe, such as non-myeloid cancer patients in the treatment of clinically significant clinically significant fever neutral cell reduction occurred in the bone marrow inhibitory anti-cancer recombination of human cell ulpotaulated.
2, gradually increase the focus of monitoring drugs key monitoring drugs at the national level of 20, to the provincial level of 35, to Jiangxi Provincial People's Hospital 50, Jiangxi Province Cancer Hospital 38, Jiangxi University of Traditional Chinese Medicine Second Affiliated Hospital 45, Jinggangshan University Affiliated Hospital 50, in addition to a few specialties such as Nanchang University affiliated oral hospital, the rest of the hospital-level varieties are in the original national, provincial-level basis to increase.
the same hainan province, Zhejiang Province, etc. have this law.
3, the future injection or key monitoring from the provincial, hospital-level key monitoring drug catalog, injection stakes in some provinces as the key monitoring drug catalog accounted for a relatively large, such as Hainan Province added 10 provincial key monitoring drug catalog, of which injection accounted for 9.
, as in Zhejiang Province, added 12 provincial-level key monitoring drug catalogues, of which injections accounted for 8.
in the hospital-level focus on monitoring drug catalog, whether it is Jinggangshan University affiliated hospital is all injections, or Jiangxi University of Traditional Chinese Medicine Second Affiliated Hospital, etc. , in the catalog has a certain amount of injection monitoring catalog.
4, medical insurance limited Chinese medicine injections priority into the 2019 version of the medical insurance drug catalog, some of the basic use of Chinese medicine injections put forward a clear request, restricting the use of the grass-roots injections from the 17th edition of 26 to 33 kinds, only the second or higher medical institutions can use, and made serious, disease and other restrictions.
through the above-mentioned provincial and hospital-level varieties can be seen, in the new version of the medical insurance drug catalog to limit the use of 33 kinds of injections at the grass-roots level, by the hospital-level monitoring of the hi-inflammatory injection, Danhong injection, wake-up quiet injection, Danhong injection and so on.
through the national, provincial and hospital-level monitoring drug catalog can be seen, nervous system treatment drugs, cardiovascular treatment drugs, tumor-assisted treatment, immunomodulation, antibacterial drugs, injections and other six major areas of drug use in the future key monitoring drug catalog or will further narrow, no direct targeted treatment of drugs will be eliminated in the new batch of key monitoring drugs catalog.
currently state-level auxiliary drug use to the provincial regional drug use to the hospital department characteristic drug three-level key monitoring drug catalog standards, in this three-level drug catalog embarrassing enterprises or will be further "embarrassing."
original title: These varieties, or are focused on monitoring.